Furthermore, intratumoral inoculation of oHSV-TRAIL inhibited tumor invasiveness, and increased survival of SCID mice bearing oHSV-resistant intracerebral GBMs (Tamura et al., 2013), revealing the unique efficacy of G47Δ-TRAIL for treatment-refractory GBM. Here, TNFSF10 is linked to glioblastoma.